8-13 Muscular Dystrophies and Muscular Dysorders Among the most common diseases in muscle are the muscular dystrophies, in which the newly identified muscle protein dystrophin is either absent or present at less than normal amounts in both Duchenne and Becker's muscular dystrophy." (Pearson,1993). Integrative Manual Therapists and other Complementary Medicine practitioners work all the time with muscle dysfunctions, strains, joint sprains, arthritis, myofascial tension but can they change the outcome in genetically based musculoskeletal disorders? Find out what the research is saying in this issue of The Burnham Review...........Buy This Issue Today
"Other major diseases of muscle include the inflammatory myopathies and neuropathies. Atrophy and hypertrophy of muscle and the relationship of aging, exercise, and fatigue all add to our understanding of the behavior of normal and abnormal muscle.
Some other interesting related diseases and disorders of muscle include myasthenia gravis, muscular dysgenesis, and myclonus.
Disorders of energy metabolism include those caused by abnormal glycolysis (Von Gierke's, Pompe's, Cori-Forbes, Andersen's, McArdle's, Hers', and Tauri's diseases) and by the acquired diseases of glycolysis (disorders of mitochondrial oxidation). Still other diseases associated with abnormal energy metabolism include lipid-related disorders (carnitine and carnitine palmitoyl-transferase deficiencies) and myotonic syndromes (myotonia congenita, paramyotonia congenita, hypokalemic and hyperkalemic periodic paralysis, and malignant hyperexia)
Diseases of the connective tissues include those of nutritional origin (scurvy, lathyrism, starvation, and protein deficiency), the genetic diseases (dermatosparaxis, Ehlers-Danlos syndrome, osteogenesis imperfecta, Marfan syndrome, homocystinuria, alcaptonuria, epidermolysis bullosa, rheumatoid arthritis in humans, polyarthritis in swine, Aleutian disease of mink, and the several types of systemic lupus erythematosus) and the acquired diseases of connective tissues (abnormal calcification, systemic sclerosis, interstitial lung disease, hepatic fibrosis, and carcinomas of the connective tissues)."1 (Pearson,1993).
Back Issues Available for $6 each
Subscriptions Available Today
for $100 per year (24 Information Packed Issues)
Go To The Shopping Cart Now
Look For These Back Issues
7-1 Benefits of Touch and NFP, The Burnham Review FREE Today
7-2 Integrative Manual Therapy (IMT) Where Is It Written?, The Burnham Review FREE Today
7-3 A Nutritional Wellness Self Study Program, The Burnham Review
7-4 NeuroAnatomy Study List for Manual Therapists, The Burnham Review
7-5 Manual Therapy and the Peace Process, The Burnham Review
Muscle Energy Technique This month's issues of The Burnham Review covers the musculoskeletal system. Muscle Energy is a technique originally used by osteopaths, now more widely used by Physical Therapists, Integrative Manual Therapist, Chiropractors and other CAM practitioner's working with hands-on approaches. My favorite references for this issue come from David Kohns, OMSIII, PT, CSCS 1. Kohns, D. (2008). "Muscle Energy Technique." Resource Manual Medicine: [Full Text] http://manualmedicine.blogspot.com/. 2. Osteopathic Health and Wellness Institute, (2008) 1000 years of osteopathy: Fred Mitchell Sr DO - Interview [Full Audio] http://www.osteopathy1000.org/fred_mitchell/fred_mitchell.htm 3. Osteopathic Health and Wellness Institute (OHWI), (2008) Muscle Energy Technique Power Point [Full Text] http://manualmedicinemuscleenergytechnique.blogspot.com/2008_01_01_archive.html 4. An Overview of Muscle Energy Concepts as Applied to Lumbar Spine Dysfunction - Sayers John Miller, PhD, PT, ATC Lumbar Spine Pain in Athletics - NATA Continuing Education [Full Audio] http://206.211.148.195/muscleenergy/miller/miller_main.html 5. NATA Research and Education Foundation (2000) Lumbar spine pain in athelets. 2000 District Lecture Series [Full Audio Visual] http://www.csuchico.edu/~sbarker/spine/ 6. Reviews/Trails/Studies: J Orthop Sports Phys Ther. 2003 Sep;33(9):502-12. Muscle energy technique in patients with acute low back pain: a pilot clinical trial. [PubMed Abstract] 7. Fryer G. (2000) Muscle energy concepts - a need for change. Journal of Osteopathic Medicine. 2000;3(2):54-59. [Full Text] http://eprints.vu.edu.au/archive/00000501/01/Muscle_energy_concepts._A_need_for_change.pdf and other references [Full Text] http://manualmedicinemuscleenergytechnique.blogspot.com/2008_01_01_archive.html
Highlighted References
PubMed Abstracts http://www.ncbi.nlm.nih.gov
http://www.nlm.nih.gov/medlineplus
General References
1. Pearson, A. M. and R. B. Young (1993). "Diseases and disorders of muscle." Adv Food Nutr Res 37: 339-423. [PubMed Abstract] 2. Wahl, M. (2008). "Exploring Surgery to Restore Muscle Power in FSH Dystrophy." Muscular Dystrophy Association: [Full Text] http://www.mda.org/Publications/Quest/q102function.html 3. Moxley, R. T., 3rd, E. L. Logigian, et al. (2007). "Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)." Muscle Nerve. [PubMed Abstract] https://urresearch.rochester.edu/handle/1802/4639 4. Kalkman, J. S., M. L. Schillings, et al. (2007). "The development of a model of fatigue in neuromuscular disorders: a longitudinal study." J Psychosom Res 62(5): 571-9. [PubMed Abstract] 5. Wahl, M. (2008). "Physical Therapy - Flexibility, Fitness and Fun." Muscular Dystrophy Association: [Full Text] http://www.mda.org/. 6. Wahl, M. (2008). "Physical Therapy - Flexibility, Fitness and Fun." Muscular Dystrophy Association: [Full Text] http://www.mda.org/. 7. de Araujo Leitao, A. V., L. A. Duro, et al. (1995). "Progressive muscular dystrophy--Duchenne type. Controversies of the kinesitherapy treatment." Sao Paulo Med J 113(5): 995-9. [PubMed Abstract] 8. Macaione, V., M. Aguennouz, et al. (2007). "RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy." Acta Neurol Scand 115(2): 115-21. [Pubmed Abstract] 9. Honda, H., Y. Mano, et al. (1987). "Inflammatory changes in affected muscles of facioscapulohumeral dystrophy." J Neurol 234(6): 408-11. [PubMed Abstract] 10. Bushby, K. M., C. Pollitt, et al. (1998). "Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports." Neuromuscul Disord 8(8): 574-9. [PubMed Abstract] 11. Yotsukura, M., K. Fujii, et al. (1998). "Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy." Am Heart J 136(2): 289-96 [PubMed Abstract] 12. Wheeler, L. (2004). "Advanced Strain Counterstrain." Massage Therapy Journal 43 Winter(4): [Full Text] www.amtamassage.org/journal/winter05_journal/mtjWinter05.html. 13. Albrecht, K. (2005). "Integrative Manual Therapy Treatment of a 12-Year-Old Female with Charcot-Marie-Tooth Syndrome: Focus on the Connection Between Biomechanics and Neurology." Journal of the Integrative Manual Therapy Association Fall(from www.imtassociation.org/Publications-Products/Journal_of_IMT/IMTA%20Journal%20final.pdf). 14. Giammatteo, T. and S. Weiselfish-Giammatteo (1997). Integrative manual therapy for the autonomic nervous system and related disorders : utilizing advanced strain and counterstrain technique. Berkeley, Calif., North Atlantic Books. [Available] www.CenterIMT.com 15. Cornolo, J., P. Mollard, et al. (2004). "Autonomic control of the cardiovascular system during acclimatization to high altitude: effects of sildenafil." J Appl Physiol 97(3): 935-40. [Full Text] http://jap.physiology.org/cgi/content/full/97/3/935 16.Apkon, S. and J. Coll (2007). "Use of Weekly Alendronate to Treat Osteoporosis in Boys with Muscular Dystrophy." Am J Phys Med Rehabil. [PubMed Abstract] 17. Massage Therapy Source Canada (2008). "Massage Therapy Source Canada: Canada's Guide to Massage Therapists and Information About Massage." [Full Text] http://massagesource.ca/therapy_glossary.phtml. 18. Guo, Z. X., R. S. Wang, et al. (1995). "[Clinical observation on treatment of 40 cases of apoplexy hemiplegia complicated shoulder-hand syndrome with electro-acupuncture]." Zhongguo Zhong Xi Yi Jie He Za Zhi 15(11): 646-8. [PubMed Abstract] 19. Folkers, K. and R. Simonsen (1995). "Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies." Biochim Biophys Acta 1271(1): 281-6. [PubMed Abstract] 20. Folkers, K., J. Wolaniuk, et al. (1985). "Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10." Proc Natl Acad Sci U S A 82(13): 4513-6. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3859873 21. Samdup, D. Z., R. G. Smith, et al. (2006). "The use of complementary and alternative medicine in children with chronic medical conditions." Am J Phys Med Rehabil 85(10): 842-6.[PubMed Abstract] 22. ------ (1998). "Meridian institute." Meridian Institute News Vol. 2 No. 2 March [Full Text] http://www.meridianinstitute.com/news2-2.htm#Healing%20Muscular 23. Thomas, N. S., K. Wiseman, et al. (2007). "A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere." J Med Genet 44(3): 215-8. [Full Text] http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=16987949 24. Pearson, A. M. and R. B. Young (1993). "Diseases and disorders of muscle." Adv Food Nutr Res 37: 339-423. [Abstract] 25. Macaione, V., M. Aguennouz, et al. (2007). "RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy." Acta Neurol Scand 115(2): 115-21. [Pubmed Abstract] 26. Celegato, B., D. Capitanio, et al. (2006). "Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes." Proteomics 6(19): 5303-21. [PubMed Abstract] 27. Honda, H., Y. Mano, et al. (1987). "Inflammatory changes in affected muscles of facioscapulohumeral dystrophy." J Neurol 234(6): 408-11. [PubMed Abstract] 28. Osborne, R. J., S. Welle, et al. (2007). "Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy." Neurology 68(8): 569-77. [PubMed Abstract] 29. Wahl, M. (2008). "Exploring Surgery to Restore Muscle Power in FSH Dystrophy." Muscular Dystrophy Association: [Full Text] http://www.mda.org/Publications/Quest/q102function.html 30. Wahl, M. (2008). "Exploring Surgery to Restore Muscle Power in FSH Dystrophy." Muscular Dystrophy Association: [Full Text] http://www.mda.org/Publications/Quest/q102function.html 31. Moxley, R. T., 3rd, E. L. Logigian, et al. (2007). "Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)." Muscle Nerve. [PubMed Abstract] https://urresearch.rochester.edu/handle/1802/4639 32. Kalkman, J. S., M. L. Schillings, et al. (2007). "The development of a model of fatigue in neuromuscular disorders: a longitudinal study." J Psychosom Res 62(5): 571-9. [PubMed Abstract] 33. Wahl, M. (2008). "Physical Therapy - Flexibility, Fitness and Fun." Muscular Dystrophy Association: [Full Text] http://www.mda.org/. 34. Wahl, M. (2008). "Physical Therapy - Flexibility, Fitness and Fun." Muscular Dystrophy Association: [Full Text] http://www.mda.org/. 35. de Araujo Leitao, A. V., L. A. Duro, et al. (1995). "Progressive muscular dystrophy--Duchenne type. Controversies of the kinesitherapy treatment." Sao Paulo Med J 113(5): 995-9. [PubMed Abstract] 36. Bushby, K. M., C. Pollitt, et al. (1998). "Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports." Neuromuscul Disord 8(8): 574-9. [PubMed Abstract] 37. Yotsukura, M., K. Fujii, et al. (1998). "Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy." Am Heart J 136(2): 289-96 [PubMed Abstract] 38.Apkon, S. and J. Coll (2007). "Use of Weekly Alendronate to Treat Osteoporosis in Boys with Muscular Dystrophy." Am J Phys Med Rehabil. [PubMed Abstract] 39. Massage Therapy Source Canada (2008). "Massage Therapy Source Canada: Canada's Guide to Massage Therapists and Information About Massage." [Full Text] http://massagesource.ca/therapy_glossary.phtml. 40. Folkers, K. and R. Simonsen (1995). "Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies." Biochim Biophys Acta 1271(1): 281-6. [PubMed Abstract] 41. Folkers, K., J. Wolaniuk, et al. (1985). "Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10." Proc Natl Acad Sci U S A 82(13): 4513-6. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3859873 42. Samdup, D. Z., R. G. Smith, et al. (2006). "The use of complementary and alternative medicine in children with chronic medical conditions." Am J Phys Med Rehabil 85(10): 842-6.[PubMed Abstract] 43. ------ (1998). "Meridian institute." Meridian Institute News Vol. 2 No. 2 March [Full Text] http://www.meridianinstitute.com/news2-2.htm#Healing%20Muscular 44. Thomas, N. S., K. Wiseman, et al. (2007). "A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere." J Med Genet 44(3): 215-8. [Full Text] http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=16987949 45. Pearson, A. M. and R. B. Young (1993). "Diseases and disorders of muscle." Adv Food Nutr Res 37: 339-423. [PubMed Abstract] 46. Macaione, V., M. Aguennouz, et al. (2007). "RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy." Acta Neurol Scand 115(2): 115-21. 47. Celegato, B., D. Capitanio, et al. (2006). "Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes." Proteomics 6(19): 5303-21. [PubMed Abstract] 48. Honda, H., Y. Mano, et al. (1987). "Inflammatory changes in affected muscles of facioscapulohumeral dystrophy." J Neurol 234(6): 408-11. [PubMed Abstract] 49. Osborne, R. J., S. Welle, et al. (2007). "Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy." Neurology 68(8): 569-77. [PubMed Abstract] 50. Wahl, M. (2008). "Exploring Surgery to Restore Muscle Power in FSH Dystrophy." Muscular Dystrophy Association: [Full Text] http://www.mda.org/Publications/Quest/q102function.html 51. Wahl, M. (2008). "Exploring Surgery to Restore Muscle Power in FSH Dystrophy." Muscular Dystrophy Association: [Full Text] http://www.mda.org/Publications/Quest/q102function.html 52. Moxley, R. T., 3rd, E. L. Logigian, et al. (2007). "Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)." Muscle Nerve. [PubMed Abstract] https://urresearch.rochester.edu/handle/1802/4639 53. Kalkman, J. S., M. L. Schillings, et al. (2007). "The development of a model of fatigue in neuromuscular disorders: a longitudinal study." J Psychosom Res 62(5): 571-9. [PubMed Abstract] 54. Wahl, M. (2008). "Physical Therapy - Flexibility, Fitness and Fun." Muscular Dystrophy Association: [Full Text] http://www.mda.org/. 55. Wahl, M. (2008). "Physical Therapy - Flexibility, Fitness and Fun." Muscular Dystrophy Association: [Full Text] http://www.mda.org/. 56. de Araujo Leitao, A. V., L. A. Duro, et al. (1995). "Progressive muscular dystrophy--Duchenne type. Controversies of the kinesitherapy treatment." Sao Paulo Med J 113(5): 995-9. [PubMed Abstract] 57. Bushby, K. M., C. Pollitt, et al. (1998). "Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports." Neuromuscul Disord 8(8): 574-9. [PubMed Abstract] 58. Yotsukura, M., K. Fujii, et al. (1998). "Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy." Am Heart J 136(2): 289-96 [PubMed Abstract] 59.Apkon, S. and J. Coll (2007). "Use of Weekly Alendronate to Treat Osteoporosis in Boys with Muscular Dystrophy." Am J Phys Med Rehabil. [PubMed Abstract] 60. Massage Therapy Source Canada (2008). "Massage Therapy Source Canada: Canada's Guide to Massage Therapists and Information About Massage." [Full Text] http://massagesource.ca/therapy_glossary.phtml. 61. Folkers, K. and R. Simonsen (1995). "Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies." Biochim Biophys Acta 1271(1): 281-6. [PubMed Abstract] 62. Folkers, K., J. Wolaniuk, et al. (1985). "Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10." Proc Natl Acad Sci U S A 82(13): 4513-6. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3859873 63. Samdup, D. Z., R. G. Smith, et al. (2006). "The use of complementary and alternative medicine in children with chronic medical conditions." Am J Phys Med Rehabil 85(10):842-6.[PubMed Abstract] 64. ------ (1998). "Meridian institute." Meridian Institute News Vol. 2 No. 2 March [Full Text] http://www.meridianinstitute.com/news2-2.htm#Healing%20Muscular